Hospital
Franklin Square Hospital Center, INC
Franklin Square Hospital Center, INC was paid $7.24M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 41% of everything it billed.
33Billing provider infoFRANKLIN SQUARE HOSPITAL CENTER, INC
BALTIMORE, MD 21237
BALTIMORE, MD 21237
33aNPI1184712085assigned 10/10/2006
33bProvider typePsychiatric Hospital Unit
28Total paid$7.24M
24GClaims216,005
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Maryland
Rank by total paid#2 of 5
Median peer was paid$4.20M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,064 | $1.79M | |
| 2019 | 35,491 | $1.53M | |
| 2020 | 27,259 | $797K | |
| 2021 | 37,304 | $829K | |
| 2022 | 33,114 | $896K | |
| 2023 | 29,437 | $902K | |
| 2024incomplete | 19,336 | $489K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 41% | 715 | 633 | $2.97M |
| G0378 | Hospital observation service, per hour | 23% | 3,393 | 2,952 | $1.64M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.5% | 3,185 | 1,913 | $615K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 5,636 | 5,109 | $499K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.6% | 5,305 | 4,682 | $479K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.3% | 5,288 | 4,154 | $238K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.3% | 2,916 | 2,572 | $166K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 826 | 607 | $150K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 8,475 | 7,516 | $108K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 1.2% | 2,511 | 2,114 | $89K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.0% | 641 | 414 | $74K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 763 | 671 | $27K |
127 more codes
| C7901 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | <1% | 495 | $27K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 369 | $23K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 4,779 | $20K |
| C7900 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | <1% | 433 | $17K |
| 87040 | <1% | 184 | $12K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,707 | $11K |
| 36591 | <1% | 1,208 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,390 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,054 | $7K |
| 96367 | <1% | 313 | $5K | |
| 93971 | <1% | 76 | $4K | |
| 80047 | <1% | 13,103 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,296 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,462 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,401 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,206 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,493 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 24,166 | $2K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $2K |
| 84484 | <1% | 7,594 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,237 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,151 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 102 | $1K |
| 97162 | <1% | 77 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,205 | $904.28 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,003 | $901.74 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 148 | $791.19 |
| 80076 | <1% | 6,296 | $693.47 | |
| 80053 | Comprehensive metabolic panel | <1% | 5,760 | $600.62 |
| 83605 | <1% | 2,004 | $595.97 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 596 | $528.69 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 602 | $457.77 |
| 96523 | <1% | 44 | $437.10 | |
| 81001 | <1% | 3,440 | $432.73 | |
| 83690 | <1% | 3,418 | $411.71 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,192 | $396.47 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 612 | $388.39 |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 12 | $382.74 |
| 71045 | Radiologic examination, chest; single view | <1% | 1,972 | $356.24 |
| 81025 | <1% | 911 | $352.73 | |
| 83880 | <1% | 1,967 | $326.13 | |
| J3490 | Unclassified drugs | <1% | 1,830 | $306.38 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 41 | $300.88 |
| 94799 | <1% | 337 | $276.52 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,057 | $274.45 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 90 | $270.84 |
| 85379 | <1% | 1,055 | $235.27 | |
| 83735 | <1% | 6,019 | $229.14 | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 40 | $227.52 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,341 | $216.55 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 607 | $198.55 |
| 81003 | <1% | 2,967 | $189.95 | |
| 85610 | <1% | 4,123 | $177.03 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 379 | $172.28 |
| 93017 | <1% | 30 | $164.06 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $140.84 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 45 | $121.60 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 105 | $103.11 |
| 80061 | Lipid panel | <1% | 268 | $84.84 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,924 | $67.59 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 877 | $60.68 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,291 | $58.37 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 72 | $57.12 |
| 94760 | <1% | 629 | $53.15 | |
| 86850 | <1% | 345 | $44.13 | |
| 84100 | <1% | 3,730 | $41.50 | |
| 83520 | <1% | 67 | $39.69 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 754 | $32.60 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 404 | $31.57 |
| 82077 | <1% | 217 | $29.56 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,951 | $24.09 |
| 82550 | <1% | 372 | $23.19 | |
| 84703 | <1% | 659 | $20.52 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,860 | $19.85 |
| 73562 | <1% | 46 | $16.57 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 24 | $15.82 |
| 82728 | <1% | 137 | $15.23 | |
| 86901 | <1% | 387 | $11.77 | |
| 86900 | <1% | 389 | $11.77 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,442 | $10.64 |
| 73030 | <1% | 15 | $9.44 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 568 | $8.74 |
| 94762 | <1% | 46 | $8.56 | |
| 87280 | <1% | 14 | $8.03 | |
| 83550 | <1% | 294 | $7.62 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 138 | $5.17 |
| 83540 | <1% | 340 | $4.63 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 253 | $3.44 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 593 | $2.81 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 934 | $2.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,223 | $1.93 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,134 | $1.37 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 78 | $0.23 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,593 | $0.01 |
| 83615 | 0% | 352 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 354 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 499 | $0.00 |
| 85730 | 0% | 116 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,036 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 26 | $0.00 |
| 82378 | 0% | 189 | $0.00 | |
| 87070 | 0% | 13 | $0.00 | |
| 82803 | 0% | 49 | $0.00 | |
| 82784 | 0% | 54 | $0.00 | |
| 90686 | 0% | 16 | $0.00 | |
| 96415 | 0% | 34 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 16 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 14 | $0.00 |
| 87077 | 0% | 13 | $0.00 | |
| 82607 | 0% | 14 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 13 | $0.00 |
| 84439 | 0% | 112 | $0.00 | |
| G0380 | Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 0% | 413 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 120 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 340 | $0.00 |
| 96417 | 0% | 175 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 309 | $0.00 |
| 84165 | 0% | 54 | $0.00 | |
| J1453 | Injection, fosaprepitant, 1 mg | 0% | 62 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 74 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 75 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 44 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 47 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 0% | 39 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 17 | $0.00 |
| 87186 | 0% | 12 | $0.00 | |
| 72100 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALLY, ROBERT (CFO)